 |
|
Home | Research Analysts’ Recent Ratings Updates for Neurocrine Biosciences (NBIX) |
 |
Research Analysts’ Recent Ratings Updates for Neurocrine Biosciences (NBIX)
|
 |
- January 23, 2015
-
Several brokerages have updated their recommendations and price targets on shares of Neurocrine Biosciences (NASDAQ: NBIX) in the last few weeks: 1/20/2015 – Neurocrine Biosciences had its price target raised by analysts at Jefferies Group from $32.00 to $39.00. They now have a “buy” rating on the stock. 1/9/2015 – Neurocrine Biosciences had its price […]This article (Research Analysts’ Recent Ratings Updates for Neurocrine Biosciences (NBIX)) was originally developed by and is property of American Banking News.
Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.
- Read more at:http://www.americanbankingnews.com/2015/01/21/research-analysts-recent-ratings-updates-for-neurocrine-biosciences-nbix/
|
 |
|
 |
|
 |
